期刊文献+

人工周期法与自然周期法准备内膜在复苏囊胚移植中效果的比较 被引量:10

Clinical Outcomes of Frozen-thawed Blastocysts Transfer in Natural or Hormonally Controlled Cycles
暂未订购
导出
摘要 目的:比较人工周期法与自然周期法准备内膜在复苏囊胚移植中的效果。方法:在复苏囊胚移植周期,分别采用外源性雌孕激素(人工周期组192个周期)和自然周期法(自然周期组54个周期)准备内膜,比较周期取消率、妊娠率、流产率、种植率等指标。结果:周期取消率、每移植周期临床妊娠率、流产率、种植率分别为:人工周期组7.3%(14/192)、53.9%(96/178)、11.5%(11/96)、38.8%(131/338);自然周期组16.7%(9/54)、68.9%(31/45)、16.1%(5/31)、52.9%(45/85),二组临床妊娠率、流产率相似,自然周期组的周期取消率和种植率明显高于人工周期组(P<0.05),但人工周期组中非PCOS患者的妊娠率(57.2%,71/124)和种植率(40.9%,95/232)与自然周期组相似。结论:在复苏囊胚移植周期,采用人工周期法准备内膜能够取得与自然周期法相似的妊娠率。 Objective: To assess the clinical outcome of frozen-thawed blastocysts transfer (FET) in natural or hormonally controlled cycles. Methods :A retrospective analysis of natural or hormonally controlled cycle was performed for 246 FET cycles, and the cancle-cycle rate, abortion rate, the clinical pregnancy rate and the implantation rate were compared. Results: Of the 192 hormonally controlled cycles, the cancel-cycle rate, the clinical pregnancy rate per ET, the abortion rate and the implantation rate were 7.3% (14/192), 53.9%(96/178), 11.5%(11/ 96), and 38.8%(131/338), respectively, whereas in 54 natural cycles, these rates were 16.7%(9/54), 68.9%(31/ 45), 16.1%(5/31) and 52.9%(45/85), respectively. There was no significant difference between the 2 groups with regard to the clinical pregnancy and abortion rate, but the cancel rate and implantation rate were higher in natural cycles. However, the pregnancy and implantation rates of patients without PCOS in hormonal control cycles (57,2%, 40.9%) were similar with those in natural cycles (P〉0.05). Conclusion: These findings suggest that both FET protocols are equally effective in terms of pregnancy outcome in women.
出处 《生殖与避孕》 CAS CSCD 北大核心 2008年第1期54-57,60,共5页 Reproduction and Contraception
关键词 IVF 囊胚移植 子宫内膜容受性 复苏囊胚 IVF blastocyst transfer endometrial respectivity frozen-thawed blastocyst
  • 相关文献

参考文献9

  • 1甄秀梅,闻姬,孙伟,陈军,王力,崔薇.冻融胚胎移植子宫内膜的准备[J].中华妇产科杂志,2003,38(3):167-168. 被引量:18
  • 2陈士岭,何锦霞,宋华东,黎淑贞,刘晓宁,李红,邢福祺.应用四种用药方案进行冻融胚胎移植的临床结局比较[J].南方医科大学学报,2007,27(3):303-306. 被引量:40
  • 3Gelbaya TA, Nardo LG, Hunter HR, et al. Cryopreservedthawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study. Fertil Steril, 2006, 85(3):603-9.
  • 4Simon A, Hurwitz A, Pharhat M, et al. A flexible protocol for artificial preparation of the endometrium without prior gonadotropin-releasing hormone agonist suppression in women with functioning ovaries undergoing frozen-thawed embryo transfer cycles, Fertil Steril, 1999, 71(4):609-13.
  • 5Gardner DK, Lane M, Stevens J, et al. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril, 2000, 73(6):1 155-8.
  • 6Andcrscn AN, Goosscns V, Gianaroli L, et al. Assistcd reproductive technology in Europe, 2003. Results generated from European registers by ESHRE. Hum Rcprocl, 2007, 22(6): 1 513-25.
  • 7郭艺红,孙莹璞,乔玉环,苏迎春,陈秋菊,陈爱军,刘新贵.多囊卵巢综合征患者卵泡液LIF、IL-1β及性激素水平与IVF-ET结局关系的研究[J].生殖与避孕,2004,24(6):344-348. 被引量:8
  • 8Avellaira C, Villavicencio A, Bacallao K, et al. Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome. Hum Reprod, 2006, 21(12):3116-21.
  • 9Quezada S, Avellaira C, Johnson MC, et al. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome. Fertil Steril, 2006, 85(4):1017-26.

二级参考文献34

  • 1张丽珠,陈贵安,刘平,李美芝,张菊.冻融胚胎移植临床妊娠成功[J].中华妇产科杂志,1994,29(12):706-707. 被引量:21
  • 2田辉,傅永伦,匡延平.无GnRH-a降调激素替代和hMG促排作子宫内膜准备对冻融胚胎移植影响的研究[J].生殖与避孕,2006,26(6):344-347. 被引量:17
  • 3Dewailly D. Definition and significance ofpolycystic ovaries.Baillieres Clin Obstet Gynaecol, 1997, 11(2):349-68.
  • 4Rizk B &amp; Aboulghar MA. Classification, pathophysiology and management of ovarian hyperstimulation syndrome. In:Peeter R Brinsden,ed. A Textbook of In vitro Fertilization and Assisted Reproduction. London: Parthenon Publishing Group, 1999, p.131.
  • 5Ozornek MH, Bielfeld P, Krussel JS, et al. Epidermal growth factor and leukaemia inhibitory factor levels in follicular fluid.Association with in vitro fertilization outcome. J Reprod Med, 1999, 44(4): 367-9.
  • 6Arici A, Oral E, Bahtiyar O, et al. Leukaemia inhibitory factor expression in human follicular fluid and ovarian cells.Hum Reprod, 1997, 12(6): 1 233-9.
  • 7Ledee-Bataille N, Lapree-Delage G, Taupin JL, et al. Follicular fluid concentration of leukaemia inhibitory factor is decreased among women with polycystic ovarian syndrome during assisted reproduction cycles. Hum Reprod, 2001,16(10): 2 073-8.
  • 8Lavranos TC, Rathjen PD &amp; Seamark RF. Tropic effects of myeloid leukaemia inhibitory factor (LIF) on mouse embryos.J Reprod Fertil, 1995, 105(2): 331-8.
  • 9Brannstrom M, Pscoe V, Norman RJ, et al. Localization of leukocyte subsets in the follicle wall and in the corpus luteum through-out the human menstrual cycle. Fertil Steril,1994, 61(3):488-95.
  • 10Baranao RI, Dain L, Palak de Fried E, et al. Human granulose cells express HLA-DR antigen and are capable of synthesizing interleukin-1. Horm Metab Res, 1995, 27(11):495-8.

共引文献60

同被引文献130

引证文献10

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部